Discontinuation and reinitiation of SGLT-2 inhibitors and GLP-1R agonists in patients with type 2 diabetes: a nationwide study from 2013 to 2021
The Lancet Regional Health - Europe（2023）
摘要
The work was funded by an unrestricted research grant from 'Department of Cardiology, Herlev and Gentofte University Hospital'.
更多查看译文
关键词
Type 2 diabetes,Cardiovascular disease,Pharmacotherapy,Epidemiology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要